Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Longitudinal assessment of metabolic and neurological decline in peripheral polyneuropathy over ten years

Dinara AzizkhojayevaKhoja Akhmet Yassawi International Kazakh-Turkish UniversityGulnaz NuskabayevaKhoja Akhmet Yassawi International Kazakh-Turkish UniversityKarlygash SadykovaKhoja Akhmet Yassawi International Kazakh-Turkish UniversityAinur TurmanbayevaKhoja Akhmet Yassawi International Kazakh-Turkish UniversityDana KaldarkhanKhoja Akhmet Yassawi International Kazakh-Turkish UniversityNurlybek MombekovKhoja Akhmet Yassawi International Kazakh-Turkish UniversityNigara YerkhojayevaKhoja Akhmet Yassawi International Kazakh-Turkish UniversityM. RaimovaDepartment of Neurology and Traditional Medicine, Tashkent State Medical UniversityUmida YodgarovaDepartment of Neurology and Traditional Medicine, Tashkent State Medical UniversitySaodat SobirovaDepartment of Neurology and Traditional Medicine, Tashkent State Medical UniversityК M MadenbayAsfendiyarov Kazakh National Medical UniversityAinash OshibayevaKhoja Akhmet Yassawi International Kazakh-Turkish University
Future Science OAjournal2026en
ABI

Аннотация

AIMS: This research aims to evaluate changes in metabolic status and the development of peripheral polyneuropathy (PN) in Kazakhstan. METHODS: This longitudinal observational study followed a cohort of adults with metabolic syndrome, comparing clinical, biochemical, and neurophysiological parameters between baseline (2014) and follow-up (2024). A total of 213 out of the original 570 participants were reexamined, with standardized assessments including anthropometry, blood tests, and electroneuromyography. RESULTS: < 0.001), and BMI and waist circumference measurements also were associated with increased odds of PN at follow-up. CONCLUSION: Adverse metabolic profiles were associated with the presence of polyneuropathy at the 10-year follow-up, including among individuals without overt diabetes. These findings highlight the importance of metabolic risk factors management to reduce the burden of PN.

Перевод пока недоступен

Темы

Идентификаторы

Цитирования и источники